Focal One completes study to expand access to robotic prostate cancer treatment

Focal One focuses high-intensity ultrasound waves on affected areas, destroying cancer cells in the gland without damaging the healthy surrounding tissue. | Source: EDAP

Earlier this year, EDAP TMS SA announced the full results of a HIFI study evaluating the high-intensity focused ultrasound, or HIFU, treatment of localized prostate cancer. The study compared the French company’s robotic Focal One system against radical prostatectomy, or RP, surgery as the first line of treatment. 

HIFI was the first prospective...